comparemela.com

Latest Breaking News On - Life sciences media inquiries - Page 1 : comparemela.com

JSR Life Sciences, LLC: Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs Targeting Cancer and Autoimmune Diseases

JSR Life Sciences, LLC ("JSR") today announced that Similis Bio ("Similis"), its business unit focused on biosimilar development, has announced plans to enter into a partnership with Novel351k to co-develop

Dennis riedlJohn gabrielsonSarfaraz niaziSimilis bioMissy bindseilKeara sauberLaura morganCrown bioscienceLife scienceLife sciences similis bioLife sciences media inquiriesJsr life sciencesSam brown incBiopharma incMarketing communicationsLife sciences

JSR Life Sciences, LLC: JSR Life Sciences Launches Similis Bio to Help Partners Accelerate Biosimilar Development

Newly launched business line leverages the combined experience and technical knowledge of leaders in analytical, cell-line, and process development to reduce up-front time and resource costs for biosimilar

Crown bioscienceMissy bindseilSimilis bioMike beyerBiopharma incMarketing communicationsLife sciencesLife sciences media inquiriesSam brown incLife sciences company inquiriesScience chief technology officer jean pierreSciences company inquiriesSciences media inquiries

JSR Life Sciences Appoints Veteran Biotech and CDMO Leader Mark W Womack to Lead KBI Biopharma and Selexis SA

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesNorth carolinaResearch triangle parkTim loweryCrown bioscienceMissy bindseilMarkw womackStelis biopharmaLife scienceLife sciences media inquiriesSam brown incBiopharma incMarketing communicationsUs navyLife sciencesLife sciences company inquiries

Pyramid Biosciences and Caris Life Sciences Announce MI Trials Collaboration for Clinical Trial Matching in Support of Study for Patients with NTRK Fusion Solid Tumors

/PRNewswire/ Pyramid Biosciences, Inc., and Caris Life Sciences® (Caris), today announced a collaboration to enhance identification of potential patients.

New yorkUnited statesMicaela rosinskiBrian lamonBrian lestiniCaris life sciences business development inquiriesCaris life sciences media inquiriesPyramid biosciences incPrecision oncology allianceMcdougall communicationsHead of biopharma business developmentCaris life sciencesPyramid biosciencesCaris lifeChief executive officerCari right in time

Pyramid Biosciences and Caris Life Sciences Announce MI Trials Collaboration for Clinical Trial Matching in Support of Study for Patients with NTRK Fusion Solid Tumors

/PRNewswire/ Pyramid Biosciences, Inc., and Caris Life Sciences® (Caris), today announced a collaboration to enhance identification of potential patients.

New yorkUnited statesMicaela rosinskiBrian lamonBrian lestiniCaris life sciences business development inquiriesCaris life sciences media inquiriesPyramid biosciences incPrecision oncology allianceMcdougall communicationsHead of biopharma business developmentCaris life sciencesPyramid biosciencesCaris lifeChief executive officerCari right in time

vimarsana © 2020. All Rights Reserved.